Lynce F - Search Results

1

Genomic Disparities in Breast Cancer Among Latinas.

Lynce F, Graves KD, Jandorf L, Ricker C, Castro E, Moreno L, Augusto B, Fejerman L, Vadaparampil ST. Lynce F, et al. Cancer Control. 2016 Oct;23(4):359-372. doi: 10.1177/107327481602300407. Cancer Control. 2016. PMID: 27842325 Free PMC article.

2

Differences in Uptake of Risk Reduction Strategies Among Underserved Populations.

Lynce F, Graves K. Lynce F, et al. EBioMedicine. 2015 Nov 3;2(11):1598-9. doi: 10.1016/j.ebiom.2015.11.001. eCollection 2015 Nov. EBioMedicine. 2015. PMID: 26870783 Free PMC article. No abstract available.

3

BRCA1/2 mutations and risk-reducing bilateral salpingo-oophorectomy among Latinas: The UPTAKE study.

Lynce F, Schlam I, Geng X, Peshkin BN, Friedman S, Dutil J, Nahleh Z, Campos C, Ricker C, Rodriguez P, Denduluri N, Ahn J, Isaacs C, Graves KD. Lynce F, et al. J Genet Couns. 2021 Apr;30(2):383-393. doi: 10.1002/jgc4.1322. Epub 2020 Oct 3. J Genet Couns. 2021. PMID: 33010199 Free PMC article.

4

Barriers and facilitators to taking CDK4/6 inhibitors among patients with metastatic breast cancer: a qualitative study.

Conley CC, McIntyre M, Pensak NA, Lynce F, Graham D, Ismail-Khan R, Lopez K, Vadaparampil ST, O'Neill SC. Conley CC, et al. Among authors: lynce f. Breast Cancer Res Treat. 2022 Apr;192(2):385-399. doi: 10.1007/s10549-022-06518-2. Epub 2022 Jan 7. Breast Cancer Res Treat. 2022. PMID: 34997364 Free PMC article.

5

Cultural adaptations to a telephone genetic counseling protocol and booklet for Latina breast cancer survivors at risk for hereditary breast and ovarian cancer.

Gómez-Trillos S, Graves KD, Fiallos K, Schwartz MD, Peshkin BN, Hamilton H, Sheppard VB, Vadaparampil ST, Campos C, Cupertino AP, Alzamora MC, Lynce F, Hurtado-de-Mendoza A. Gómez-Trillos S, et al. Among authors: lynce f. Transl Behav Med. 2023 May 13;13(5):297-308. doi: 10.1093/tbm/ibac106. Transl Behav Med. 2023. PMID: 36694918 Free PMC article.

6

Pertuzumab for the treatment of breast cancer.

Lynce F, Swain SM. Lynce F, et al. Cancer Invest. 2014 Oct;32(8):430-8. doi: 10.3109/07357907.2014.922570. Epub 2014 Jun 12. Cancer Invest. 2014. PMID: 24921704 Review.

7

Racial Disparities in the Molecular Landscape of Cancer.

Heath EI, Lynce F, Xiu J, Ellerbrock A, Reddy SK, Obeid E, Liu SV, Bollig-Fischer A, Separovic D, Vanderwalde A. Heath EI, et al. Among authors: lynce f. Anticancer Res. 2018 Apr;38(4):2235-2240. doi: 10.21873/anticanres.12466. Anticancer Res. 2018. PMID: 29599344 Free PMC article.

8

Incidence, characteristics, and management of central nervous system metastases in patients with inflammatory breast cancer.

Warren LEG, Niman SM, Remolano MC, Landry JM, Nakhlis F, Bellon JR, Aizer AA, Lin NU, Tolaney SM, Regan MM, Overmoyer BA, Lynce F. Warren LEG, et al. Among authors: lynce f. Cancer. 2022 Dec 1;128(23):4085-4094. doi: 10.1002/cncr.34441. Epub 2022 Oct 10. Cancer. 2022. PMID: 36210737 Free article.

9

Initiation of Trastuzumab by Women Younger Than 64 Years for Adjuvant Treatment of Stage I-III Breast Cancer.

Tsai HT, Isaacs C, Lynce FC, O'Neill SC, Liu C, Schwartz MD, Selvam N, Zhou Y, Potosky AL. Tsai HT, et al. J Natl Compr Canc Netw. 2017 May;15(5):601-607. doi: 10.6004/jnccn.2017.0063. J Natl Compr Canc Netw. 2017. PMID: 28476740 Free PMC article.

10

HER2-low inflammatory breast cancer: Clinicopathologic features and prognostic implications.

Tarantino P, Niman SM, Erick TK, Priedigkeit N, Harrison BT, Giordano A, Nakhlis F, Bellon JR, Parker T, Strauss S, Jin Q, King TA, Overmoyer BA, Curigliano G, Regan MM, Tolaney SM, Lynce F. Tarantino P, et al. Among authors: lynce f. Eur J Cancer. 2022 Oct;174:277-286. doi: 10.1016/j.ejca.2022.07.001. Eur J Cancer. 2022. PMID: 36116830

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page